Bank of America reiterates Amedisys (NASDAQ:AMED) with a Buy and raises the price target from $163 to $170.
Bank of America Reiterates Buy on Amedisys, Raises Price Target to $170
Bank of America reiterates Amedisys (NASDAQ:AMED) with a Buy and raises the price target from $163 to $170.
Benzinga · 11/20/2019 16:24